Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 166Rituximab 155Specimen Handling 114Biopsy 91Magnetic Resonance Spectroscopy 90Vincristine 85Doxorubicin 79Prednisone 78fludarabine 69venetoclax 67obinutuzumab 62ibrutinib 54Lenalidomide 53Dexamethasone 53Cytarabine 47Methotrexate 44acalabrutinib 42Etoposide 41CT-P10 40blinatumomab 38fludarabine phosphate 34Bendamustine Hydrochloride 34prednylidene 32Gemcitabine 32deltacortene 31Calcium Dobesilate 30zanubrutinib 29pembrolizumab 29glofitamab 28Nivolumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Particle Accelerators × Lymphoid × 90 days × Clear all
NCT07608549 2026-05-27

FLASH Pilot Phase 1 Safety Study

Dartmouth-Hitchcock Medical Center

Phase NA Not yet recruiting
10 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡